Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  CRDL

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.


TSX:CRDL - Post by User

Bullboard Posts
Comment by vikingguyon Jul 17, 2020 3:23pm
185 Views
Post# 31282864

RE:RE:RE:RE:RE:Covid-19 traction coming

RE:RE:RE:RE:RE:Covid-19 traction comingI should have stated that unofficially both Cardiol and Shoppers have said it will be available soon. I emailed Shoppers asking about the product and got this reply;

 while, at this time an ETA on the Cardiol THC free CBD product has not been announced, we hope to have it in stock as soon as possible. Because the product is not currently available, we took the posting of the product off of our website at this time. Have a look on our website at least once a week; if the product becomes available you will be able to view it even if you are not registered. You may then register with us and place an order once you are approved.

My friend who is eagerly awaiting the product for her daughter called and they told her "yes, it will be availble soon". 

I believe the market for the product could surprise us to the upside. There is a huge problem in the industry with inconsistent and mislabled products. People will pay up for a sure thing. Does anyone know what the cost of Epidiolex is in the states? Would be interesting to find out as it is virtually the same thing, with our product having even less thc. 

I understand your frustrations Youhillman as you know I share them as well. I've been told that things will start to unfold very soon and what chose do we have but to believe them? Insiders and those close to the company are the only ones that really know whats going on behind the scenes and they all loaded up on the latest financing so what does that tell you. Anyways, have a good weekend all. Cheers 
Bullboard Posts